Monashee Investment Management’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Monashee Investment Management’s Portfolio CHAQ.WS Stock Details CHAQ.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-150,000	Closed	-$96K	–	501
2021 Q2	$96K	Hold	150,000	–	–	0.01%	325
2021 Q1	$141K	Hold	150,000	–	–	0.02%	272
2020 Q4	$149K	Hold	150,000	–	–	0.02%	232
2020 Q3	$108K	Hold	150,000	–	–	0.02%	145
2020 Q2	$104K	Buy	+150,000	New	+$102K	0.02%	173

Monashee Investment Management's CHAQ.WS Position: Q3 2021 in Review

Monashee Investment Management sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 150,000 shares — an estimated $96K sold.

Monashee Investment Management first reported a position in CHAQ.WS in Q2 2020 and held it in 5 quarters. The position peaked at $149K in Q4 2020. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

Monashee Investment Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
Monashee Investment Management sold 150,000 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $96K.
Monashee Investment Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q2 2020 and held it in 5 quarters.
Monashee Investment Management's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $149K in Q4 2020.
0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on Monashee Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.